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Abstract 
RAD51 is an indispensable homologous recombination protein, necessary for strand 
invasion and crossing over. It has recently been designated as a Fanconi anemia (FA) gene, 
following the discovery of two patients carrying dominant negative mutations. FA is a 
hereditary DNA repair disorder characterized by various congenital abnormalities, 
progressive bone marrow failure and cancer predisposition. In this paper, we describe the 
first viable vertebrate model of RAD51 loss. Zebrafish rad51 loss-of-function mutants 
developed key features of FA, including hypocellular kidney marrow, sensitivity to 
crosslinking agents and decreased size. We show that some of these symptoms stem from 
both decreased proliferation and increased apoptosis of embryonic hematopoietic stem and 
progenitor cells. Co-mutation of p53 was able to rescue the hematopoietic defects seen in 
the single mutants, but led to tumor development. We further demonstrate that prolonged  
inflammatory stress can exacerbate the hematological impairment, leading to an additional 
decrease in kidney marrow cell numbers. These findings strengthen the assignment of 
RAD51 as a Fanconi gene and provide more evidence for the notion that aberrant p53 
signaling during embryogenesis leads to the hematological defects seen later in life in FA. 
Further research on this novel zebrafish FA model will lead to a deeper understanding of the 
molecular basis of bone marrow failure in FA and the cellular role of RAD51.  
 
Significance statement:  
The homologous recombination protein RAD51 has been extensively studied in prokaryotes 
and lower eukaryotes. However, there is a significant lack of knowledge of the role of this 
protein and its regulation in an in-vivo context in vertebrates. Here we report the first viable 
vertebrate mutant model of rad51 in zebrafish. These mutant fish enabled us to confirm for 
the first time the recently discovered role of RAD51 in Fanconi anemia pathogenesis. We 
report that p53 linked embryonic stem cell defects directly lead to hematological impairments 
later in life. Co-mutation of rad51 with p53 rescues the observed hematological defects, but 
predisposes the fish to early tumor development. The application of this model opens new 
possibilities to advance Fanconi anemia drug discovery. 
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Introduction  
Fanconi anemia (FA) is a hereditary DNA repair disorder characterized by various congenital 
abnormalities, progressive bone marrow failure (BMF) and cancer predisposition(1). It is 
caused by mutations in one of 21 genes in the FA pathway(2–4). The FA pathway has been 
shown to be the major route for the removal of interstrand crosslinks (ICL) - DNA lesions that 
prevent replication and transcription by inhibiting DNA strand separation(5, 6). When the 
pathway is defective, these structures cannot be removed, potentially leading to cell 
death(7). Indeed, sensitivity to crosslinking agents, such as mitomycin C, is an absolute 
diagnostic criterion of FA(8). 
  
Although FA is characterized by remarkable phenotypic heterogeneity, FA patients usually 
succumb to the depletion of hematopoietic stem and progenitor cells (HSPCs) in their bone 
marrow, leading to pancytopenia and complete BMF. Therefore, bone marrow 
transplantation (BMT) is the only modality that offers a potential cure of hematopoietic 
defects but is itself associated with considerable morbidity(9, 10).  Interestingly, a decrease 
in  HSPCs (CD34+ cells) is already apparent in FA infants even before the first 
hematological symptoms appear(11). This led to the hypothesis that FA originates from 
defects during the formation of the initial HSPC pool, presumably due to an overactive 
p53/p21 response and cell cycle arrest(11). In agreement with this, FA mice have 
considerably smaller fetal livers than their healthy siblings(12). It remains unclear however, 
at which stage during embryonic development these defects appear and how perturbation in 
the  production of embryonic HSPCs relates to the phenotype seen in adulthood.  
 
Due to the role FA genes play in the repair of interstrand crosslinks, DNA damaging agents 
causing ICLs have been proposed as a major cause of  BMF, with small aldehydes  being 
the most likely candidates. Co-mutation of genes in the FA pathway and aldehyde 
metabolizing genes (Aldh2 and Adh5) resulted in significant reduction of HSPCs and BMF in 
double mutant mice(13–17). In addition, FA patients lacking ALDH2 show a more severe 
phenotype(18, 19). Apart from their hypersensitivity to crosslinking agents, FA cells also 
react excessively to pro-apoptotic cytokines such as IFNγ and TNFα(20–25). However, the 
role of cytokines in the etiology of BMF remains controversial(26–29). 
 
In the last two years, a novel FA subtype associated with dominant-negative mutations in 
RAD51 was reported, leading to the designation of RAD51 as FANCR(30–32). It has been 
shown to be involved in protecting broken down replication forks from excess processing by 
nucleases, linking the FA pathway with RAD51/BRCA2(30, 33). In-vivo studies of Rad51 
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have previously been very difficult, as mice lacking the protein invariably die during early 
embryogenesis(34, 35).  
 
In this study, we characterized the first viable vertebrate model of Rad51 loss. Indeed, our 
zebrafish rad51 loss of function mutant recapitulates many congenital and haematological 
features of FA. We provide the first in-vivo evidence that decreased HSPC numbers during 
embryonic development directly lead to the later bone marrow defects in FA. Finally, we 
show that rad51 mutants  do not overproduce inflammatory cytokines, but are more sensitive 
to  them and that prolonged inflammatory stress can further reduce marrow cellularity.  
 
Results 
The rad51sa23805 allele leads to complete loss of functional Rad51 
To study the function of Rad51 in hematopoiesis, we obtained fish carrying the rad51sa23805 
allele from the Sanger Institute Zebrafish Mutation Project(36). The rad51sa23805 allele has a 
C>T mutation at codon 203 in exon 7, which leads to a premature stop codon in the region 
of the RecA domain. In contrast to mice lacking Rad51, which invariably die during early 
development(34, 35), fish carrying homozygous copies of the rad51sa23805 (referred to as 
rad51-/- for brevity in the text) survive to adulthood. However, all surviving adults undergo 
sex reversal and are infertile males, lacking mature spermatozoa in the testes (Figure S1A 
and B).  
 
To ensure complete loss of function of the rad51sa23805 allele, we carried out a Western blot 
on testicular tissue, since Rad51 is highly expressed in germ cells in zebrafish and other 
species(37, 38). This confirmed that the full-length protein is lost in rad51-/- fish (Figure 1A). 
However, immunostaining for Rad51 at the one-cell stage embryos i.e prior to maternal to 
zygotic transition(39) showed diffuse staining in the cytoplasm of all embryos resulting from 
a rad51+/- incross  (Figure 1B). This suggested that rad51-/- embryos have maternally 
derived Rad51. 
 
Due to the early embryonic lethality of murine Rad51 mutants(34, 35), we decided to look at 
the functional redundancy between rad51 and its paralogues. To do this, we knocked out 
rad51l1, the fish orthologue of the human RAD51B gene using CRISPR. Initially, we raised 
204 embryos resulting from a rad51+/-, rad51l1+/- incross to adulthood. However, out of 
these none were double mutants, even though 12.75 would be expected from Mendelian 
inheritance. We repeated the same cross and collected embryos at 4 dpf. Again, 0 out of 44 
embryos were double mutants, even though 2.75 would have been expected. Finally, we 
repeated the cross and genotyped at 6 hpf (the earliest point the genotyping works reliably). 
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Out of 47 embryos, none were double mutants. This early embryonic synthetic lethality of co-
mutation indicates that rad51 and rad51l1 have at least some redundant functionality. 
 
Lack of Rad51 in embryos leads to increased DNA damage sensitivity 
Rad51 is essential for the repair of interstrand crosslinks (ICLs) and double stranded breaks 
via homologous recombination (HR). In ICL repair, it plays a role in both HR-linked 
processes HR, as well as HR-independent steps(30–32). To investigate the role of Rad51 in 
the repair of ICLs, we treated embryos resulting from an incross of rad51+/- parents with the 
crosslinking agents diepoxybutane (DEB) and mitomycin C (MMC) as well as the 
topoisomerase I inhibitor camptothecin (CPT)  and the PARP-1 inhibitor 1,5-isoquinolinediol 
(DiQ). After treatment, the tails of the embryos were used for chromosome spreads, whereas 
the heads were kept for genotyping. The spreads revealed that DEB induced defects 
characteristic for FA, including breaks and radials structures (Figure 1C). MMC induced 
many of the same features, but also led to considerably more premature chromatid 
separation events (Figure S2A). Similarly, CPT induced high levels of chromosome breaks, 
but few radial structures (Figure S2B). DiQ on the other hand was embryonic lethal at higher 
concentration (100 µM) but at lower levels (10 µM) induced just a  few breaks in both wt and 
mutant embryos (Figure S2C).  
 
We also examined the role of Rad51 in the repair of other forms of double stranded breaks 
not involving crosslinking agents. For this, we irradiated 24 hour old embryos from an incross 
of rad51+/- parents with gamma radiation and examined them at 48 hpf. The irradiated 
embryos were then blindly imaged, scored and genotyped. The rad51-/- embryos developed 
small eyes and heads in response to radiation (Figure 1Di). This phenotype was limited to 
the rad51-/- embryos (Figure 1Dii), showing that they are more sensitive to irradiation than 
wt siblings. In addition, pH2AX (a marker of double stranded breaks) immunostaining of non-
irradiated embryos revealed extensive DNA damage in embryos lacking Rad51 in 
comparison to their wt siblings (Figure 1Ei and ii). Taken together, these data suggest that 
rad51-/- embryos are hypersensitive to DNA damage. 
 
Finally, we considered the role of non-homologous end joining (NHEJ) in the survival of our 
mutant fish. To do that, we treated an incross of rad51+/- parents with a range of different 
concentrations of SCR-7, a DNA ligase IV inhibitor and scored the embryos at 24 hpf (Figure 
S3). At the lowest concentration, embryos were completely unaffected, whereas at the 
higher concentration all embryos died. At no concentration were the mutant embryos more 
sensitive than their wt siblings (Figure S3), indicating that NHEJ is dispensable for the 
survival of rad51-/- embryos. 
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Rad51 mutants recapitulate many congenital and hematological features of Fanconi 
anemia 
RAD51 mutations were recently linked to FA in humans in two case reports(30, 31). 
Therefore, we examined the rad51 mutant fish for congenital and hematological features 
associated with FA. A common congenital symptom of FA is decreased height(1). On 
account of that, we measured  body length of fish with and without rad51 mutation 
throughout development. Although embryonic development was not affected by the 
mutation, the size of rad51-/- fish was decreased compared to their wt siblings, starting from 
around 23 dpf (Figure S4A). The size reduction during the larval period was maintained to 
adulthood with rad51 mutant fish being on average 10% shorter than their wt siblings (Figure 
S4B and C). In addition, rad51-/- embryos and larvae developed microphthalmia, another 
distinct feature of FA patients (Figure S5).  
 
To assess whether loss of rad51 affects adult hematopoiesis, we inspected the kidney 
marrow (WKM) of zebrafish, which is analogous to bone marrow in mammals. Unlike in 
mammals, there is only one kidney in zebrafish, which is the only site of adult 
haematopoiesis. Importantly, there is no space restriction of the marrow by the rigid bone, as 
kidney tissue is very spongy and flexible. We first obtained several H&E stained histological 
sections each of the kidney of four wt and mutant fish ranging between four and eight 
months of age. Representative sections showed no noticeable qualitative differences 
between rad51+/+ and -/- fish (Figure 2A). However, even though the morphology appeared 
normal, kidney size and cell number were considerably (~50%) decreased in rad51-/- fish 
(Figure 2Bi and ii). The kidney cellularity of rad51-/- fish gradually decreased with aging, but 
at the same rate as in wt fish (Figure 2Bii) suggesting that the mutants established steady 
state hematopoiesis despite displaying kidney hypocellularity. Although rad51 mutants did 
not develop cytopenia in the peripheral blood (PB) (Figure 2C), they did accumulate 
macrocytic erythrocytes in the PB (Figure 2D), suggesting a gradual worsening of the 
phenotype over time. 
 
Rad51-/- fish show a hyperproliferative phenotype in the kidney marrow 
The number of cells in the WKM is determined by the balance between their proliferation and 
apoptosis rate, as well as their migration to the PB. To test whether the decrease in kidney 
cell numbers in rad51 mutants was due to apoptosis, we carried out an AnnexinV-Propodium 
Iodide (AV-PI) staining assay on kidney tissue (Figure 3A and Figure S6A and B). We 
observed no statistically significant difference between rad51+/+ and -/- fish, excluding 
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apoptosis as an initial cause for the decrease in cell numbers in the kidney. Therefore, we 
next focused on the proliferation of the kidney marrow cells.  
 
The standard assay for assessing cell proliferation rates is the incorporation of BrdU into the 
DNA. To follow the kinetics of BrdU incorporation and dilution via division and/or migration to 
the circulation, we measured BrdU labeling at several time points post injection (Figure 3B). 
Since erythrocytes are nucleated in zebrafish, our analysis was not limited only to leukocytes 
and allowed us to robustly assess changes in WKM as well as in PB. The initial number of 
BrdU+ cells in the WKM was two-fold higher in rad51-/- fish compared to the control (Figure 
3Ci and Figure S6F), suggesting an increased proliferation rate in the mutant. This was 
followed by a fast dilution of the BrdU label over two weeks, because of the increased cell 
division of mutant HSPCs (Figure 3Ci). In line with this, the initial number of BrdU+ cells in 
the PB was higher in rad51-/- fish compared to wt siblings (Figure 3Cii), but then plateaued 
faster due the dilution of the label in the kidney (Figure 3Cii). 
  
To show that blood, rather than other cells in WKM are proliferating, we generated mutants 
in various transgenic backgrounds. The rad51-/- Tg(gata1a:EGFP) line(40), was used to 
assess the erythrocytic lineage, including erythrocytic progenitors. The rad51-/- 
Tg(cd41/itga2b:EGFP)(41) line was employed to detect thrombocytic progenitors, which are 
labeled in the cd41:EGFPdim subpopulation(42). Consistent with the BrdU incorporation 
experiments, we saw an increase in newly made gata1:EGFP+ erythrocytes in the kidney 
(Figure 3D and Figure S6C), as well as an increase in cd41:EGFPdim thrombocytic 
progenitors (Figure 3E and Figure S6D).  
 
Together, this evidence shows that loss of rad51 leads to a hyperproliferation of HSPCs, 
possibly as a compensatory mechanism to prevent cytopenia in the PB. However, the 
lowered cellularity of the kidney in adult rad51-/- fish cannot be explained by this finding, 
suggesting that the kidney cytopenia stems from an early, possibly embryonic HSPC defect.  
 
Lack of Rad51 causes an HSPC defect during early development 
The definitive wave of hematopoiesis starts at around 30 hpf when long-term HSCs are 
formed from endothelial cells of the ventral wall of the dorsal aorta. These newly made HSCs 
move to the caudal hematopoietic tissue (CHT), which serves as an intermediate place of 
hematopoiesis in which the HSCs expand greatly, akin to the mammalian fetal liver(43).  
 
To assess the underlying cause of the decreased number of cells in the adult kidney of FA 
fish,  we focused on embryonic hematopoiesis. To this end, we utilized whole-mount in-situ 
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hybridisation (ISH) using a cmyb-specific probe, which labels HSPCs. Indeed, at 2 dpf, 
rad51-/- embryos had a decreased number of HSPCs compared to the wt embryos from the 
same clutch (Figure 4Ai and ii). At 4 dpf, the difference in the number of HSPCs in the CHT 
of rad51-/- and wt embryos was further exacerbated (Figure 4Bi and ii). 
 
Following up on that finding, we carried out a BrdU incorporation assay on the tail tissue of 2 
dpf embryos, which showed that the proliferation rate in the tail of rad51-/- embryos was 
about half that of rad51+/+ embryos (Figure 4C). Although not statistically significant this 
trend was still apparent in the CHT at 4 dpf (Figure 4D).  
 
In addition to proliferation, we also investigated apoptosis at 2 dpf by carrying out a TUNEL 
assay on several crosses of rad51 heterozygotes. This revealed a twofold increase in 
apoptosis in the CHT in mutants compared to wt embryos (Figure 4E and F). Taken 
together, our data imply that the cytopenia in the adult kidney is caused by an increase 
apoptosis of HSPCs as well as reduced proliferation during early embryogenesis, mainly 
before 4 dpf.  
 
The HSPC defects in rad51-/- fish are mediated via p53 
The defects seen in FA have recently been linked to an aggravated p53 response (Ceccaldi 
et al 2012). To focus on the role of p53 in the HSPC defect we generated a zebrafish line 
carrying mutations in both rad51 and p53. This double mutation was able to rescue the 
number of HSPCs in the CHT of 4 dpf embryos (Figure 5A and Table S3). Importantly, the 
number of cells in the adult WKM of p53-/- rad51-/- fish reached wt levels by 4 mpf (Figure 
5B). Along with the rescued marrow cellularity, there was no difference in the proliferation of 
cells in the WKM of wt and double mutant fish at 4 mpf, as shown by a BrdU incorporation 
assay (Figure 5C).  
 
We also examined the congenital phenotypes in the double mutants. The sex reversal seen 
in rad51 single mutants was corrected (Figure S7A-C), but the size defect was not (Figure 
S7D). However, neither female, nor male double mutants were fertile (Figure S7A-C). Taken 
together, our data suggest that the marrow hypocellularity in adult fish was not due to the 
smaller size of rad51 mutant, meaning that these two phenotypes are uncoupled. Instead, 
we observed a high correlation between the number of HSPCs generated early during 
embryonic development and the kidney marrow cellularity in adulthood. Therefore, the 
rescue in the embryonic definitive hematopoiesis can revert all defects observed in adult 
hematopoiesis in rad51 mutants.  
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Finally, the tumor incidence of the double mutants was 30%, with the first tumors developing 
from 5 mpf (five months earlier than reported for p53 single mutants(44)). The tumors 
resembled malignant peripheral nerve sheath tumors (MPNSTs), (Figure S7E-F), which is 
the most common type of malignancy in p53-/- fish(44). None of the other fish (i.e. wt, rad51 
mutants and heterozygotes) developed any kind of noticeable tumor, including the oldest 13 
mpf rad51-/- fish. 
 
Rad51-/- fish are more sensitive to inflammatory stress 
An aberrant inflammatory response has been postulated to be one of the potential causes of 
the BMF in FA. This is thought to be due increased expression of inflammatory cytokines in 
FA patients and an excess apoptosis of HSPCs in response to these factors. To test this 
hypothesis, we developed a zebrafish model of prolonged inflammatory stress. Over a 
period of four weeks, we injected rad51-/- and wt fish with the immunostimulant 
polyinosinic:polycytidylic acid (pI:pC) and assessed changes in the kidney cellularity, lineage 
output and the expression of genes associated with inflammation (Figure 6A).  
 
PI:pC resembles double-stranded RNA and is known to induce the expression of 
proinflammatory cytokines such as TNFα(45) and IL1(46). Therefore, it has been considered 
to accurately mimic viral infection(46) in murine and fish models(45–48). Indeed, a single IP 
injection of pI:pC in zebrafish induced robust inflammatory response just six hours 
postinjection (Figure S8A). Mutants did not express more inflammatory cytokines when 
unchallenged (Figure S8B). Importantly, the prolonged exposure of adult wt fish to pI:pC 
resulted in a twofold increased production of monocytes  (Figure 6B) but did not overtly 
affected kidney marrow cellularity or cell viability (Figure 6C and D). In addition, we observed 
clear upregulation of monocyte specific genes (Figure S8C). The skew towards monocyte 
production in turn decreased the erythrocyte output and to a lesser extent other lineages. In 
contrast, repeated pI:pC injections of rad51-/- fish led to no significant change in the number 
of produced monocytes (Figure 6B) and a ~25% decrease in the total number of cells in the 
kidney (Figure 6C). As in the wt fish, the prolonged inflammation decreased the number of 
erythrocytes in the kidney marrow of rad51-/- fish thus possibly contributing to the overall 
reduction in kidney cellularity. This was mediated by a normalization of proliferation rates in 
the kidneys of pI:pC injected mutant fish (Figure 6E and S8D). Therefore, the prolonged 
inflammatory stress can lead to severe marrow defects in our rad51-/- zebrafish FA model 
not only in terms of the lineage output but also by affecting the total marrow cellularity.  
  
Interestingly, the unchallenged rad51 mutants downregulated p53, but showed an 
exaggerated reaction in p53 expression to repeated inflammatory stress (Figure 6Fi). Fitting 
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with this observation, p21 expression followed a similar trend in gene expression in non-
injected and pI:pC injected mutants (Figure 6Fii). 
 
Rad51-/- WKM cells are unaffected by acetaldehyde induced stress 
DNA damage induced by small aldehydes has been proposed as a major cause of  
exhaustion of the HSCs in the bone marrow of FA patients(13–19). To examine the 
sensitivity of rad51 mutants to acetaldehyde we exposed them to acetaldehyde-induced 
stress over a period of four weeks (Figure S9A). Our analysis revealed an increase in WKM 
cellularity in wt fish in all blood cell types (Figure S9B and C) upon acetaldehyde injections, 
whereas rad51 mutant cell numbers were unaffected. The viability of WKM cells was 
decreased to a similar extent in both wt and mutant fish (Figure S9D), but with no change in 
p53 expression in WKM (Figure S9E). 
 
Discussion 
The Fanconi anemia genes encode proteins that function cooperatively in the Fanconi DNA 
repair pathway. Here we characterized the first viable vertebrate rad51 loss of function 
mutant. Loss of rad51 in zebrafish recapitulated many congenital features of FA, such as 
short stature and microphthalmia(1); as well as hematological defects, including marrow 
cytopenia and accumulation of macrocytic erythrocytes in circulation(1, 8). Most importantly, 
rad51-/- fish showed increased sensitivity to crosslinking agents, an absolute diagnostic 
criterion of FA(8). 
 
Furthermore, our results show that loss of rad51 does not lead to higher sensitivity to PARP 
inhibitors. Previous research on mammalian cells showed that BRCA1/2 mutant cells are 
more sensitive to PARP inhibition. One model proposes that this is due to the importance of 
PARP-1 in reactivating stalled replication forks in HR-deficient cells(49). That model is not 
compatible with our data, suggesting that PARP-BRCA synthetic lethality stems from 
functions unrelated to HR. PARP1 is highly conserved between zebrafish and humans 
(~70%). A small molecule inhibitor such as DiQ should therefore be able to enter the 
zebrafish embryos and inhibit the enzyme the same way as in human cells. Further 
evidence for this is provided by the lethality of high doses of this drug in wt and rad51 
mutant fish. However, we were unable to obtain brca2 mutant zebrafish and use as a 
positive control for DNA damage in response to PARP inhibition. This should be taken 
into account when interpreting our findings. 
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Although loss of Rad51 leads to an early embryonic death in mice(34, 35), zebrafish lacking 
rad51 survive to adulthood. This is not entirely surprising, as fish lacking brca2 also survive 
to adulthood(50, 51), whereas Brca2 mutant mice die before birth(52, 53). It has been 
hypothesized that maternal mRNA contributes to embryonic viability of zebrafish 
mutants(50). This seems likely, considering the presence of maternally derived Rad51 in 
rad51 mutant embryos. However, another plausible explanation is the functional redundancy 
between rad51 and its paralog rad51l1 in zebrafish.  Our analysis suggests that rad51 and 
rad51l1 are able to partially compensate for each other, leading to the lethality of double 
mutants. In contrast, NHEJ did not appear to play a role in compensating for the loss of HR. 
Interestingly, rad51-/- fish, like brca2-/- fish show sex reversal that can be rescued upon p53 
co-mutation(50, 51). Additional p53 loss further caused development  of MPNSTs in both 
brca2 and rad51 mutants, which occurred considerably earlier and at the higher incidence 
than in p53 single mutants(44, 50, 51, 54). 
  
FA is genetically and phenotypically heterogeneous disorder, but bone marrow failure is the 
most common cause of death(1) with patients having lowered CD34+ progenitor cell 
numbers from birth(11, 55). This led to hypothesis that hematological defects in FA originate 
from an impairment of HSPCs during embryonic development, which leads to a decreased 
number of HSPCs at birth(11, 12). Here we provide the first in-vivo evidence that the 
decrease in HSPC numbers in adult fish indeed stems from a combination of decreased 
proliferation and increased apoptosis during embryonic development. This defect appears to 
be mediated via p53(11), as our p53/rad51 double mutants did not display any observable 
hematological defects in embryos or adults. 
 
In agreement with our study, knockdown of fancd2 in zebrafish embryos causes massive 
apoptosis in the whole body, associated with upregulation of genes in the p53 pathway, as 
well as decreased expression of cyclins. Strikingly, co-knockdown of p53 rescued both the 
cyclin down-regulation, as well as apoptosis(56), resembling the situation in our fish and 
providing further evidence for the importance of p53 signalling. This phenotype is, however, 
only partly consistent with what was observed in murine fetal Fancd2-/- cells. In the murine 
model the reduced number of HSPCs was set off by p38 mediated reduced proliferation, 
without any involvement of apoptosis or p53 signaling(57). More research into the causes of 
the early HSPC defects and how they can be mitigated is warranted. Due to the external 
development and their transparency zebrafish embryos would be an ideal tool to discover 
compounds that can alleviate these defects. 
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The decreased  WKM cellularity in rad51 zebrafish mutants also mirrors defects seen in Lig4 
(a protein involved in non-homologous end-joining) mutant mice, which show decreased BM 
cell numbers, coupled to an approximately twofold increase in proliferation of LT-HSCs(58). 
This underlines the importance of repairing double stranded breaks in HSC maintenance 
and suggests hyperproliferation of blood progenitors might be a common mechanism to 
cope with decreased cell numbers in the kidney/bone marrow. However, like most murine FA 
models(59, 60), the fish never progressed to pancytopenia or spontaneous BMF/KMF, which 
is probably due to species differences in the HSC compartment, lifespan and rearing 
conditions. Nevertheless, together with the clinical data(30, 31), these facts provide further 
evidence for the designation of RAD51 as FANCR and show that our rad51-/- fish are a 
suitable model for FA. 
 
The progressive decline of HSC numbers in FA patients leads to BMF and there is a  
considerable evidence for an overproduction of inflammatory cytokines in patients and 
mouse models(27, 61–65). Furthermore, inflammatory stress (for example by repeated pI:pC 
injections) can induce BMF in mouse models of FA(66, 67). We did not observe an increase 
in inflammatory cytokines in our unchallenged rad51 mutants, ruling out cytokine 
overproduction as a cause for hematological defects. We did, however, observe a 25% 
decrease in WKM cellularity after repeated of pI:pC injections, possibly due to decreased 
proliferation compared to unchallenged fish. Unlike wt fish, rad51 mutants were unable to 
respond appropriately to inflammation and increase monocyte production. The decrease in 
WKM cellularity as a result of inflammatory stress was accompanied by an upregulation of 
p53, again underlining the high importance of this pathway in the etiology of FA and 
explaining the normalized proliferation. Interestingly, we were unable to elicit similar changes 
using acetaldehyde, indicating that damage induced by small aldehydes is not a major factor 
in FA pathogenesis, at least after birth. 
 
Our study characterized the first viable vertebrate model of RAD51 loss, which recapitulates 
many human FA symptoms and is thus also the first zebrafish model of the disease. Further 
study of this mutant will increase our knowledge of the cellular roles of RAD51 in-vivo and 
will deepen our understanding of the molecular pathology of FA. Transparency of zebrafish 
embryos, their high fecundity and the existence of transgenic lines labelling various blood 
lineages makes them very amenable for high-throughput screening  in comparison to other 
model organisms. The application of the rad51 mutant line will significantly impact the 
development of novel therapeutics to improve HSPC function in FA patients, by screening 
for molecules that can alleviate the HSPC reduction in embryos.  
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Methods 
Zebrafish care and strains 
Fish lines were maintained in the Sanger Institute zebrafish facility according to EU 
regulations. Wild type fish were of the Tübingen long fin strain. Fish were genotyped as 
described previously(36). 
  
Western blotting 
Western blotting was carried out as described previously(68). 
Antibodies can be found in supplementary Table 1. 
  
Embryo irradiation 
Embryos were irradiated at 24 hpf in a Gammacell 1000 Elite Blood Irradiator (MDS 
Nordiron) at 750 cGy. 
  
Immunostaining 
Staining was carried out as described(69). We used Hoechst 33342 as nuclear stain. 
Embryos were imaged on a Leica SP-5 confocal microscope using a 40X water immersion 
lens. Antibodies can be found in Table S1. 
 
Chromosome spreads 
Embryos were treated with 1µg/ml diepoxybutane (Sigma Aldrich), 5 µg/ml mitomycin C 
(Sigma Aldrich), 1 nM camptothecin (Sigma Aldrich) or 10 µM 1,5-isoquinolinediol (Sigma 
Aldrich) in egg water between 4 and 24 hpf. From here on we followed the Zebrafish Book 
4th edition(70), but kept the head of each embryo for genotyping. VECTASHIELD mounting 
medium with DAPI was used to visualize the spreads. 
 
NHEJ inhibition 
Embryos were treated with 1, 10, 25, 50, 75 and 100µM SCR-7 (Sigma Aldrich) at 4 hpf. 
Embryos were scored for defects at 24 hpf. 
 
CRISPR-Cas9 
Mutations in rad51l1 were induced at exon two, leading to a seven bp deletion (478-
484delTGGGTCC in the cDNA). 
The targeted DNA sequence was 5’-GGATGTCCTGTCGGTCACCCAGG-3’.  
ssDNA oligonucleotides 5’-TAGGATGTCCTGTCGGTCACCC-3’ and  
5’-AAACGGGTGACCGACAGGACAT-3’ (Sigma-Aldrich) were annealed and ligated with 
pDR274 vector (Addgene) linearized with BsaI (New England Biolabs) to make guide RNA 
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(gRNA) expression vector. gRNA was prepared with MAXIscript T7 kit (Life Technologies) 
using DraI-linearized gRNA expression vector as a template, while Cas9 mRNA was 
synthesized using mMESSAGE mMACHINE T7 kit (Ambion) and pMLM3613 expression 
vector (Addgene) linearized with PmeI (New England Biolabs). Zebrafish embryos were 
injected at 1-cell stage with 12.5 pg of gRNA and 160 pg of Cas9 mRNA. For a detailed 
zebrafish CRISPR methodology see Brocal 2016(71). 
 
Histology 
Formalin fixed tissues were processed and sectioned using standard techniques(72) 
followed by staining with Harris hematoxylin and eosin (H&E). 
 
AnnexinV-PI assay 
We used the Alexa Fluor® 488 Annexin V/Dead Cell Apoptosis Kit (Thermo Fisher) 
according to the manufacturer’s instructions. 
 
BrdU assay on adults 
Fish were injected with 10 µl of 10 mg/ml 5-bromo-2'-deoxyuridine (BrdU, Sigma Aldrich) 
and culled at 1, 7 or 14 days post injection. We extracted kidney and blood , made single cell 
suspensions and fixed cells in 70% EtOH overnight. BrdU immunostaining was carried out 
as described previously(68), after which the cells were resuspended in PBS and analyzed 
using FACS. 
 
BrdU assay on embryos 
Embryos were chilled on ice for 15 minutes. This was followed by a 20-minute incubation in 
10 mM BrdU on ice. After a 3 h recovery in egg water, embryos were fixed in 4% PFA. 
Heads from embryos were used for genotyping. For 2 dpf embryos, the whole tails were 
pooled according to genotype, whereas for 4 dpf embryos just the CHT was dissected.   
Samples were treated with 10mM DTT in 1X Danieau’s solution for 30 minutes at room 
temperature, followed by incubation in liberase (Roche) in PBS for 3 hours at 37˚C. The 
reaction was stopped by replacing the solution with 5%FBS/PBS. Single cell suspensions 
were fixed in 70% ethanol overnight. From here on, the staining process and analysis was 
identical to cells obtained from adults. Antibodies can be found in Table S1. 
 
TUNEL assays 
Embryos for TUNEL assays were fixed and stored as for ISH. Staining was carried out using 
the In Situ Cell Death Detection Kit, AP (Roche) according to the manufacturer’s instructions. 
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Kidney FACS 
Dissected kidneys were placed in 5%FBS/PBS and processed to single cell suspensions. 
Dead cells were excluded using 4',6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich Inc.) or 
propidium iodide (PI). Flow cytometry was carried out on a MoFlo XDP (Beckman Coulter), a 
BD LSRFortessa, or a BD Influx (BD Biosciences). 
 
In-situ hybridization (ISH) 
In-situ hybridization was carried out as described previously(73). We used a cmyb antisense 
probe. Embryos were blindly sorted into high, medium and low staining conditions followed 
by genotyping. 
  
Long-term pI:pC injections 
Fish were injected with 10 mg/ml polyinosinic:polycytidylic acid (pI:pC, Sigma-Aldrich) once 
a week, totaling 4 injections. Fish were culled one or three days after the last injection. 
Optionally, 10 mg/ml BrdU were added to the last injection. Kidneys were processed to 
single cell suspensions for FACS, as described above and cell numbers counted. Remaining 
cell suspensions were used for gene expression analysis. 
 
Long-term acetaldehyde injections 
The same protocol as for the pI:pC injections was followed, but using 10µl 1% acetaldehyde 
(Sigma Aldrich) in PBS instead for the injections. 
  
qPCRs 
The qPCR reaction used SYBR green (Thermo Fisher) and run on a QuantStudio 3 (Thermo 
Fisher) qPCR machine. Statistics were carried out on raw ΔCt values. Primers used are 
listed in Table S2. 
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Figure Legends 
Figure 1. The rad51sa23805 allele leads to loss of Rad51 protein and causes DNA 
damage sensitivity. (A) Western blot showing the expression of Rad51 in testes extracts of 
wild type (wt) and mutant zebrafish. Beta-actin was used as a loading control. (B) 
Representative Rad51 immunostained embryos derived from a rad51+/- incross. Secondary 
only (i), Abcam primary (ii), AnaSpec primary (iii). (C) Chromosome spreads of 24 hpf wild 
type and mutant embryos treated with 1 µg/ml diepoxybutane for 20 hours. White arrows 
indicate characteristic damage (chromosome breaks and radial structures) in response to 
crosslinking agents (i). Quantification of the damage (ii). Mann-Whitney test, P=.0004, 
n+/+=25, n-/-=26. (D) Comparison of the response of 48 hpf wild type and mutant embryos to 
irradiation (i). The black arrow indicates the small head and eye phenotype, which is 
quantified in ii. Two-tailed Fisher’s exact test pooling wild types and heterozygotes as control 
group, P<0.001, n=67. (E) Immunostaining for pH2AX in wild type and mutant embryos with 
representative embryos (i) and quantification of foci (ii). White arrows indicate example foci. 
Two-tailed Student’s t-test, P<.0001,  n+/+=8, n-/-=11. 
 
Figure 2. Adult rad51 mutant fish display kidney marrow cytopenia. (A) H&E stained 
histological sections of 4 mpf wild type and mutant kidneys using a 20X objective. Muscle 
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(red arrow), ducts/tubules (grey arrow) and hematopoietic kidney marrow (black arrow) can 
be seen. The scale bar is 100 µm. (B) Fixed 8 mpf wild type and mutant kidneys (i); 
quantification of the number of total cells per freshly isolated kidney at different ages using a 
hemocytometer (ii). Two-way ANOVA was used and type III model fit (Armitage 2001). The 
test shows  a significant influence of age (F (1,50)=18.23, P<.0001) and mutation status (F 
(1,50)=10.87, P=.0018) on phenotype. 4 mpf  n+/+=6, n-/-=6; 8 mpf  n+/+=16, n-/-=16; 13 mpf 
n+/+=6,  n-/-=4. (C) Quantification of peripheral blood (PB) cells in wild type and mutant fish at 
4 mpf. Two-sided T-test, n+/+=6, n-/-=6. (D) In i, blood smears of 13 mpf wild type (top) and 
mutant fish (bottom) are compared. Scale bar=10 µm. In ii, the change is quantified using 
two-way ANOVA and a type III model fit (Armitage 2001). There was a statistically significant 
interaction between age and mutation status (F (1, 28)=12.89 P=.0012), no significant 
influence of age (F (1, 28)=180.76, P=.392) and no significant influence of mutation status (F 
(1, 28)=2.88, P=.1006). P-value shown on the graph stems from a post-hoc Tukey multiple 
comparison test. 4 mpf: n+/+=6,  n-/-=6, 8 mpf: n+/+=5, n-/-=5, 13 mpf: n+/+=6,  n-/-=4   Bars 
represent mean +/- SEM. 
 
Figure 3. HSPCs in the kidney adult rad51 mutant fish show increased proliferation 
(A) AnnexinV-PI assay to assess apoptosis in the kidney. Two-sided T-test, n+/+=4, n-/-=4.  
(B) Schematic of the experimental design for the BrdU incorporation experiments . Fish were 
injected once with 10 mg/ml BrdU and culled after 1, 7 or 14 days to obtain the blood and 
kidney marrow for antibody staining and FACS analysis. (C) Percentage of BrdU+ cells in 
the kidney (i). Two sided Student’s t-test, P=.024 at 1 dpi and P>.05 at 14 dpi. 1 dpi n+/+=5, n-
/-=6; 7 dpi  n+/+=6, n-/-=6; 14 dpi n+/+=5, n-/-=5.  Percentage of BrdU+ cells in the peripheral 
blood (ii). Two sided Student’s t-test, P=.0015 at 1 dpi and P>.05 at 14 dpi. 1 dpi n+/+=5, n-/-
=6; 7 dpi n+/+=6, n-/-=5; 14 dpi n+/+=5, n-/-=5. (D) Percentage of gata1:GFP+ cells in the kidney 
at 4 mpf. Two sided Student’s t-test, P=.025,  n+/+=6, n-/-=6. (E)  Percentage of dim and bright 
cd41:GFP+ cells in the kidney at 4 mpf, labeling thrombocytic progenitors and mature 
thrombocytes respectively. Two-tailed Student’s t-test. Thrombocytic progenitors: P=.023, 
mature thrombocytes: P=n.s.,  n+/+=10, n-/-=10. Bars represent mean +/- SEM in all graphs. 
   
Figure 4. The rad51sa23805 HSPC defect starts during embryonic development. (A) In-situ 
hybridization using a cmyb-specific probe at 2 dpf; The arrow shows HSPCs. Representative 
images of the three different staining categories are shown on the left and a quantification of 
the different genotypes on the right, n=119 from 2 clutches. (B) Quantification of BrdU+ cells 
in the tail at 2 dpf. Two-sided Student’s t-test, P=0.042, n+/+=3, n-/-=3. (C) In-situ hybridization 
using a cmyb-specific probe at 4 dpf; The arrow shows HSPCs. Representative images of 
the three different staining categories are shown on the left and a quantification of the 
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different genotypes on the right, n=120 from 2 clutches. (D) Quantification of BrdU+ cells in 
the CHT at 4 dpf. Two-sided Student’s t-test,  n+/+=4, n-/-=4. Bars represent mean +/- SEM in 
B and D. (E) Representative images of TUNEL-stained 2 dpf embryos from a rad51+/- 
incross. Dotted lines indicate the area of the CHT that was scored. Arrows indicate TUNEL+ 
cells. (F) Quantification of 3 clutches of TUNEL-stained 2 dpf rad51+/- incrosses. Each 
clutch was scored blindly and consisted of 10 +/+ and 10 -/- embryos each. Shown is the 
mean of all clutches +/- SEM. 
 
Figure 5. The HSPC defects in rad51sa23805 fish are rescued in a p53 mutant 
background. 
(A) Representative images of 4 dpf embryos resulting from in-crosses of p53+/- rad51+/- 
parents stained using a cmyb-specific probe. The total number of embryos used (all 
genotypes) n=237 from 4 clutches. For information about all genotypes please see Table S3.  
(B) Percentage of BrdU+ cells in the kidney at 4 mpf at 1 dpi. Two-sided Student’s t-test, 
np53+/+ rad51+/+=5, np53-/- rad51-/-=5. (C) Number of total cells per kidney at 4 mpf quantified using a 
hemocytometer. Analysis using one-way ANOVA (F (3,43=10.45), P<.0001), individual p-
values shown in the figure are from Tukey’s post-hoc test, np53+/+ rad51+/+=16, np53+/+ rad51-/-=16, 
np53-/- rad51+/+=6., np53-/- rad51-/-=8. Bars represent mean +/- SEM in B and C. 
 
Figure 6. Lack of Rad51 causes increased sensitivity to prolonged inflammatory 
stress.  
(A) Schematic of the experimental design. Both wild type and rad51-/- fish were injected 
every seven days with 10 µl 10 mg/ml polyinosinic:polycytidylic acid, four injections in total. 
All fish were culled 3 days after the last injection. Control fish were not injected; Rad51+/+, 
nnon-injected=10, ninjected=9; Rad51-/-, nnon-injected=8, ninjected=9. (B) Absolute number of cells 
belonging to different blood lineages in the kidney gained by combining FACS data with the 
cell counts shown in A. Statistical tests were carried out individually for each cell type, using 
two-way ANOVA. P-value shown on the graph stems from a post-hoc Šidak multiple 
comparison test, comparing non-injected to injected fish within each genotype. For all 
groups, n is the same as in A. (C) The total number of cells in the kidney in injected and non-
injected fish. Two-way ANOVA was carried out on the reciprocal of the data to fulfill the 
requirement of homoscedasticity as measured by Bartlett’s test (before transformation: 
P=.0002, after transformation: P=.095). There was a statistically significant effect of mutation 
status (F (1,32)=29.86, P<.0001) and of injection status (F (1,32)=6.778, P=.014). P-value 
shown on the graph stems from a post-hoc Tukey multiple comparison test. For all groups, n 
is the same as in A. (D) Viable cells as determined by PI-staining. Two-way ANOVA 
revealed a significant influence of injection status (F (1,32)=100.1, P<.0001). P-values on the 
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graph stem from a post-hoc Tukey multiple comparison test Bars represent mean +/- SEM in 
B, C and D. (E) Percentage of BrdU+ cells in the WKM of wild type (wt) and mutant (ko) fish 
in response to pI:pC. 1I=one injection, 2I=two injections, 4I=four injections.  (F) Relative 
expression of genes linked to apoptosis and proliferation. (i)  p53. P-value shown on the 
graph stems from a post-hoc Tukey multiple comparison test. (ii) p21. Bars represent 
geometric mean +/- 95% CI in E and F.   
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